AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
1-Year Return
29.75%
This Quarter Return
+11.4%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$254M
AUM Growth
-$6.12M
(-2.4%)
Cap. Flow
-$43.8M
Cap. Flow
% of AUM
-17.22%
Top 10 Holdings %
Top 10 Hldgs %
51.68%
Holding
90
New
19
Increased
14
Reduced
15
Closed
19
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$12M |
| 2 |
Biogen
BIIB
|
$11.4M |
| 3 |
Prothena Corp
PRTA
|
$6.83M |
| 4 |
Establishment Labs
ESTA
|
$6.75M |
| 5 |
Kura Oncology
KURA
|
$5.85M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$25.2M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$16.1M |
| 3 |
Merck
MRK
|
$12.8M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$6.35M |
| 5 |
Ventyx Biosciences
VTYX
|
$5.23M |
Sector Composition
| 1 | Healthcare | 94.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
77
Viridian Therapeutics
VRDN
$1.52B
| – | – |
0
| – | – |
|
|
PVLA
78
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| – | – |
-3,837
| Closed | -$300K |
|
|
NARI
79
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-20,000
| Closed | -$1.23M |
|
|
KRTX
80
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-12,500
| Closed | -$2.27M |
|
|
ARAV
81
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
0
| – | – |
|
|
PNT
82
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-149,586
| Closed | -$1.09M |
|
|
SGEN
83
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-20,000
| Closed | -$4.05M |
|
|
BLU
84
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-881,329
| Closed | -$6.35M |
|
|
RXDX
85
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-150,000
| Closed | -$16.1M |
|
|
HZNP
86
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-20,000
| Closed | -$2.18M |
|